Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Helyezés a részvények között #340
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Részvényárfolyam
$49.11
Piaci kapitalizáció
$73.00B
Változás (1 nap)
2.22%
Változás (1 év)
-53.96%
Ország
US
Kereskedés Boston Scientific Corporation (BSX)

Kategória

Bevétel a(z) Boston Scientific Corporation (BSX) részvényhez
Bevétel ekkor: Jun 2026 TTM: $21.00B
Boston Scientific Corporation legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $21.00B. 2024 évben a vállalat $16.75B árbevételt ért el, amely növekedés a 2023 évben elért $14.24B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Boston Scientific Corporation bevételtörténete 2000 és 2026 között
Bevétel az év végén
Év Bevétel Változtassa meg
2026 (TTM) $21.00B 4.59%
2025 $20.07B 19.87%
2024 $16.75B 17.61%
2023 $14.24B 12.29%
2022 $12.68B 6.68%
2021 $11.89B 19.92%
2020 $9.91B -7.66%
2019 $10.74B 9.28%
2018 $9.82B 8.57%
2017 $9.05B 7.89%
2016 $8.39B 12.16%
2015 $7.48B 1.31%
2014 $7.38B 3.32%
2013 $7.14B -1.46%
2012 $7.25B -4.89%
2011 $7.62B -2.36%
2010 $7.81B -4.67%
2009 $8.19B 1.71%
2008 $8.05B -3.67%
2007 $8.36B 6.85%
2006 $7.82B 24.48%
2005 $6.28B 11.72%
2004 $5.62B 61.80%
2003 $3.48B 19.08%
2002 $2.92B 9.20%
2001 $2.67B 0.34%
2000 $2.66B 0.00%
Hasonló cégek vagy versenytársak bevétele
Vállalat Bevétel Bevételkülönbség Ország
$46.59B 121.88%
US
$25.84B 23.06%
US
$35.48B 69.00%
IE
$6.51B -68.98%
US
- -
DE